Tag: Therapeutics

The convergence of One Medicine and advanced therapeutics

Which is more sensitive, sacrificing hundreds of laboratory mice during the development of a therapeutic or using highly advanced model systems such as organs-on-a-chip for early drug development work and carrying out animal validation in, say, six cows which in fact model many human diseases better than mice do? This was one of the questions posed by the panel at …

Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure

July 7, 2022 — Tenaya Therapeutics, Inc., a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced the publication of preclinical research in the July 6 issue of Science Translational Medicine. The article, titled “Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse …

Veterinary Therapeutics Market [+Primary Research] | Forecast Analysis By 2031

Veterinary Therapeutics Market Veterinary Therapeutics Market Analysis Growth Forecast Analysis By Manufacturers Regions Type And To 2031 NEW YORK CITY, NEW YORK, UNITED STATES, July 7, 2022 /EINPresswire.com/ — Global Veterinary Therapeutics Market Report covers market Industry Summary, competitive landscape, segmentation,Veterinary Therapeutics Market with Key Factor Analysis, size, share, growth analysis , trends and strategies of Veterinary Therapeutics industry. The …

Ankyra Therapeutics Announces Research Collaboration with the College of Veterinary Medicine at the University of Illinois at Urbana-Champaign

BOSTON–(BUSINESS WIRE)–Ankyra Therapeutics is pleased to announce that it has entered into a formal research collaboration with the College of Veterinary Medicine at the University of Illinois Urbana-Champaign. Ankyra is developing a novel anchored immunotherapy platform that allows retention of immune-oncology drugs in the tumor microenvironment for several weeks. This promotes local immune-mediated tumor regression while limiting systemic toxicity. Ankyra …

NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson’s and Motor Neuron Disease

£2.68 million Biomedical Catalyst (BMC) early-stage award funded in part by Innovate UK to support development of disease-modifying medicines for debilitating chronic neurodegenerative disorders NRG has a pipeline of brain-penetrant small molecule inhibitors of the mitochondrial permeability transition pore (mPTP) with potential as first-in-class treatments for Parkinson’s disease (PD) and motor neuron disease (MND) Cambridge, UK, 30 May 2022 – …

NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson’s and Motor Neuron Disease

£2.68 million Biomedical Catalyst (BMC) early-stage award funded in part by Innovate UK to support development of disease-modifying medicines for debilitating chronic neurodegenerative disorders NRG has a pipeline of brain-penetrant small molecule inhibitors of the mitochondrial permeability transition pore (mPTP) with potential as first-in-class treatments for Parkinson’s disease (PD) and motor neuron disease (MND) CAMBRIDGE, UK, May 30, 2022 /PRNewswire/ …

Jaguar Health Announces Napo Therapeutics’ Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition

Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to significant morbidity and mortality from severe secretory diarrhea SAN FRANCISCO, CA / ACCESSWIRE / May 25, 2022 / Jaguar Health (NASDAQ:JAGX) announced today that Napo Therapeutics, the Italian corporation established by the company in Italy in 2021 that focuses on …

Veterinary Therapeutics Market Revenue Predicted to Go Up by 2022-2026

“ The Veterinary Therapeutics market study examined the main influences of market growth. The driving factors that influence favorably the demand for Veterinary Therapeutics’s, restrictive factors that limit market expansion, and their impact on the global Veterinary Therapeutics market are explored in detail. In the reporting research, trends that shape the market and influence market growth are further identified and …

Equine Veterinary Therapeutics Market Key Manufactures, Insights and Industry Trends Analyzed till Period, 2027| Merck Animal Heath, Affymetrix, Elanco Animal Heath, Zoetis (Pfizer Animal Health), Equine Health UK, – Cleveland Sports Zone

“ A research study conducted on the Equine Veterinary Therapeutics market offers substantial information about market size and estimation, market share, growth, and product significance. The Equine Veterinary Therapeutics market report consists of a thorough analysis of the market which will help clients acquire Equine Veterinary Therapeutics market knowledge and use for business purposes. This report provides data to the …